|
|
|
LETTER FROM THE BOARD OF
DIRECTORS
|
|

|
Dear Fellow Shareholder,
While Philip Morris International Inc. (PMI) is
widely known as a cigarette company, in 2016 it announced its new
purpose: to deliver a smoke-free future by focusing its
resources on developing, scientifically substantiating and
responsibly commercializing smoke-free products that are less
harmful than smoking, with the aim of completely replacing
cigarettes as soon as possible. These innovative alternative
products do not burn tobacco, do not create cigarette smoke and
therefore generate significantly lower levels of carcinogens and
other toxic substances compared to cigarettes.
Building on the Board’s Letter to Shareholders in
PMI’s 2017 Proxy Statement, we would like to reaffirm PMI’s purpose
and acknowledge that, as the Company continues to transform its
business and organization, its core effort to provide smoke-free alternatives that are
satisfying to today’s adult smokers—and to work hard to convince
them to switch—will not be enough. The Company needs to continue
earning the trust and active cooperation of a host of stakeholders,
from its supply chain partners to regulators and public health
authorities.
A smoke-free future is attainable, and the benefits
it can bring to the people who would otherwise continue to smoke,
and hence to global public health, are enormous. However, the
Company cannot succeed alone. Together with governments and civil
society we can maximize this opportunity through a consensus that
smoke-free alternatives,
when subject to proper government oversight and regulation, are
part of sound tobacco policy.
The Quest for Better Alternatives for Adult Smokers
Smoking causes serious disease, and the best way to
avoid the harms of smoking is never to start, or to quit. For
decades, tobacco control has focused on strict fiscal, marketing
and other measures to deter initiation and to encourage cessation.
These must be continued. Nevertheless, while smoking prevalence
rates continue to slowly decline, the World Health Organization
projects that the estimated number of 1.1 billion people who smoke
tobacco products today will remain largely unchanged by 2025,
reflecting population growth.
Nicotine, while addictive and not risk free, is not
the primary cause of smoking-related disease. The primary cause is
the harmful chemicals released or generated by the burning of
tobacco and contained in the smoke. Eliminating combustion from
nicotine-containing
products is the way to significantly reduce their toxicity. Thanks
to rapid advances in science and technology, and strong PMI
commitment, these products are now a reality.
Currently, PMI’s smoke-free portfolio comprises
platforms that heat tobacco, vaporize nicotine-containing liquids
or essentially contain only nicotine, all without combustion. Their
development and manufacturing follow high standards of quality and
consistency. The scientific evaluation to substantiate their harm
reduction potential compared to cigarette smoking is based on
rigorous pre-clinical and clinical assessments and sophisticated
systems toxicology. The results are publicly available, are
peer-reviewed and have been submitted to numerous regulatory
authorities, including the U.S. Food and Drug Administration. The
totality of the scientific evidence makes the Company confident
that switching completely to these products is likely to present
less risk of harm than continuing to smoke. Post-market
surveillance is necessary to continue building this confidence,
and, over time, quantify the reduction in morbidity and mortality
through epidemiology.
To be clear, these smoke-free alternatives are not
risk free and should not be used by youth or non-smokers. For those
who use nicotine in any form it is best to quit completely. The
Company must market them responsibly, so as to minimize any
unintended use, while maximizing the switching of adult smokers who
would otherwise continue smoking.
IQOS Platform 1, a heat-not-burn
tobacco product, was commercially launched in late 2015 and was
very well received by adult smokers, with conversion rates
exceeding 70 percent. This confirmed that the Company had the
products and the science to fulfill its ambition to completely
replace cigarettes. In 2016, with the full support of the Board of
Directors, the Company announced its new purpose of delivering a
smoke-free future. Since then the Company has fully aligned its
employees with this purpose, and swiftly shifted its organizational
focus and resources to smoke-free alternatives. The Company is
essentially disrupting its traditional business from the inside out
and is leading the industry in this unprecedented
transformation.
PMI 2020 Proxy Statement • 3